Failure to Heed Combat Methamphetamine Act Proves Costly for CVS Pharmacy in $77M Settlement

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Enforcement

Failure to Heed Combat Methamphetamine Act Proves Costly for CVS Pharmacy in $77M Settlement

Staff Writers

December 31, 2010 at 19:00:00 ET

CVS Pharmacy Inc., a subsidiary of Rhode Island-based CVS Caremark Corp., agreed to fines and forfeitures of some $77.6 million in an Oct. 14, 2010, settlement with the Department of Justice. The largest U.S. operator of retail pharmacies admitted that it unlawfully sold large quantities of pseudoephedrine containing O-T-C drugs, which were later used as source chemicals in the ma... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Failure to Heed Combat Methamphetamine Act Proves Costly for CVS Pharmacy in $77M Settlement

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT